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A twenty-month-old Chihuahua male dog was presented
to us suffering with ataxia. Based on the physical examination,
X-ray and magnetic resonance imaging (MRI) examinations,
we diagnosed the dog with hydrocephalus, Chiari I
malformation and syringomyelia. Treatment consisted of
internal medical treatment and the placement of a
ventriculoperitoneal (VP) shunt. The ventricular dilatation
was relieved and the dog improved neurologically; however,
the Chiari I malformation and syringomyelia remained
after surgically positioning the VP shunt.
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Hydrocephalus is the term commonly used to describe a
condition of abnormal dilation of the ventricular system
within the cranium. Ventricular dilation occurs in dogs
because of a variety of intracranial disease processes [4].
The choice of treatment is generally dictated by the physical
status, the age of the animal and the cause of the
hydrocephalus. Medical treatment may include general
supportive care and administering medications to limit the
production of cerebrospinal fluid (CSF) and so reduce the
intracranial pressure. Surgery is generally required for those
animals that do not improve within 2 weeks and
ventriculoperitoneal (VP) shunts are most commonly used
in small animals [10]. This paper describes a dog suffering
with hydrocephalus that underwent VP shunting.
A twenty-month-old Chihuahua male dog was presented
to the Yamaguchi University Veterinary Medical Hospital
(YUVMH) with ataxia. The owner reported that the dog
once foamed at the mouth 8 months ago and the dog’s gait
consisted of swaying with short strides; the walking
symptoms had waxed and waned in the last week. The dog
had received its vaccinations and had recently been started
on a regiment of oral dexamethasone (0.5 mg per dog, SID)
by the referring veterinarian.
Upon presentation to the YUVMH, the dog appeared
normally conscious, but ataxic and weak, and it had a dome-
shaped calvarium. The open fontanelle was palpated. There
were no abnormalities on the neurological examination,
including evaluation of the postural reaction and spinal
reflex, but there was a weak reaction in the papillary light
reflex and no reaction for the menace response was
observed. A complete blood count (CBC) revealed that all
the values were within the normal range. The serum
biochemistry abnormalities included elevation of alanine
aminotransferase (ALT; 224 IU/l, reference range: 13 to 53
IU/l) and alkaline phosphatase (ALP; 167IU/l, reference
range: 0 to 142 IU/l), and mild hypokalemia (3.2 mEq/l,
reference range: 3.4 to 5.2 mEq/l). An x-ray examination
revealed a mildly enlarged skull, an open fontanelle and
partial protrusion of the occipital bone (Fig. 1). MRI
(Hitachi MRP-20; Hitachi, Japan) revealed asymmetrically
enlarged lateral ventricles and slight dilation of the third
ventricle (Fig. 2). We also found syringomyelia in the region
of C2, 3 and 4 and caudal (foramen magnum) descent of
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Fig. 1. Lateral radiography reveals a mildly enlarged skull, a n
open fontanelle and a partial protrusion on the occipital bone.204 Heejaung Kim et al.
the cerebellum (Chiari I malformation). A diagnosis of
hydrocephalus was made and medical treatment
(dexamethasone 0.1mg per dog, acetazolamide 5 mg/kg,
furosemide 1 mg/kg, BI) was first administered.
The owner reported a few days later that the dog did not
show any improvement of the clinical signs and it showed
more frequent episodes of ataxia, stupor and partial seizure.
After consulting with the owner, the decision was made to
surgically place a VP shunt in order to divert the excess fluid
in the cranial vault to the peritoneal cavity.
The VP shunt (LPV II Valves and Kits; Heyer-Schulte
Neurocare, USA) was placed using the method described by
Bagley [1] and Harrington et al. [4]. The ventricular catheter
was placed into the left lateral ventricle through the parietal
bone and the distal end of the catheter was implanted into
the peritoneal cavity (Fig. 3).
Seven days after the surgery, the dog recovered and it was
neurologically normal; the dog was discharged 2 weeks
later. Four moths after surgery, the MRI (Fig. 4) revealed
that dilation of the ventricles was relieved, but the Chiari I
malformation and the syringomyelia remained intact.
Hydrocephalus may be classified into a primary or
secondary condition, and it does not always result in clinical
signs and symptoms. Primary (congenital) hydrocephalus is
apparently due to failure of the arachnoid villi to reabsorb
CSF at an adequate rate. Other cases of congenital
hydrocephalus involve a narrowed mesencephalic aqueduct
with obstruction of the CSF flow. The most common
clinical findings in the patients with hydrocephalus include:
seizures, visual deficits, slowed learning and dementia.
Secondary (noncomunicating) hydrocephalus results from
impaired CSF movement. This may be due to ventricular
obstruction (e.g., secondary to neoplasms) or to impaired
CSF resorption at the arachnoid villi, and this is usually as a
consequence of prior inflammation. Although the clinical
course for congenital hydrocephalus is usually slowly
progressive, secondary hydrocephalus is often rapidly
progressive and it’s associated with a massive elevation of
the intracranial pressure [3].
In this case, a Chihuahua dog with a dome-shaped
calvarium was presented with ataxia. Chihuahuas are
predisposed to congenital hydrocephalus and this malady is
most often seen in young dogs, prior to ossification of the
cranial sutures. Hydrocephalus may contribute to abnormalities
of skull development such as a thinning of the bone
structure, a dome-shaped or bossed appearance to the head
or a persistent fontanelle [10].
The dog was treated with dexamethasone, acetazolamide
Fig. 2. T1-weighed transverse (A) and T2-weighed sagittal (B) MRI scans, demonstrating asymmetrically enlarged lateral ventricles,
slight dilation of the third ventricle, syringomyelia in the region of C2, 3, 4 (B, arrowhead) and caudal (foramen magnum) desc ent of the
cerebellum (Chiari I malformation) (B, arrow).
Fig. 3. The VP shunt was placed into the left lateral ventricle (arrow) and the peritoneal cavity (arrowhead).Hydrocephalus in a dog with syringomyelia and Chiari I malformation 205
and frosemide before VP shunting. Steroids are known to
increase CSF resorption, and diuretics diminish CSF
production [10]. However, there has been only limited
success for the long-term therapy of primary hydrocephalus
with using maintenance prednisone. Short-term administration
of diuretics may decrease the intracranial pressure, but their
long-term use may be associated with systemic electrolyte
disturbances [3].
On the MRI examination, we found not only asymmetric
dilatation of the lateral ventricles, but also Chiari I
malformation and syringomyelia (Fig. 2). Chiari I malformation
is a disorder of an uncertain origin that has been traditionally
defined as the downward herniation of the cerebellar tonsils
through the foramen magnum [9]. Syringomyelia is a cystic
cavity of the spinal cord that contains fluid identical or
similar to the CSF and extracellular fluid (ECF). The cavity
may be formed by a dilatation of the central canal or it may
lie within the parenchymal substance [8]. Chiari I malformation
is a leading cause of syringomyelia [9], however, the
pathogenesis of syringomyelia associated with Chiari I
malformation is still not fully understood.
In this case, the dog had an open fontanelle and a very thin
skull, so it was difficult to place the ventricular catheter into
the lateral ventricle. We used coagulants (carbazochrome
sodium sulfonate, tranexamic acid) and antibiotics (cefazolin,
cephalexin) following surgery to control infection and
hemorrhage, which are the most common causes of shunt
obstruction [6]. There are some reports of VP shunting
complications such as inadequate drainage, infection,
overdrainage and seizures [5,6,7,11]. Overshunting may
lead to slit-ventricle syndrome, low intracranial pressure
syndrome, subdural hematoma or hydroma, craniostenosis,
microencephaly and aqueduct stenosis or obstruction.
Continuous efforts and adequate treatment should be carried
out to overcome these possible complications.
After VP shunting surgery, the dog did not show any
neurological abnormalities; however, Chiari I malformation
and syringomyelia still remained. Thus, we can suggest that
the ataxia was mainly a result of hydrocepahalus and that
Chiari I malformation and syringomyelia did not contribute
to the clinical disorders in this case. Some papers have
reported that Chiari I malformation or syringomyelia could
be treated with instituting control of the CSF circulation
[2,7,9].
Modern science and technology could suggest using
cellular and tissue therapies for the treatment of hydrocephalus.
By using tissue engineering techniques, transplantation of
the cells or tissue that have a great capacity for water
absorption into the subrarachnoid space or under the scalp
with a connection to the ventricle could relieve hydrocephalus
[6]. This new treatment method should be explored as
another alternative for treating hydrocephalus.
The VP shunting relieved the ventricular dilation of this
dog that suffered with hydrocephalus and that presented for
ataxia, yet the Chiari I malformation and syringomyelia
remained. VP shunts are most commonly used in small
animals and a successful outcome may be more likely in the
animals that display minimal clinical signs and symptoms
[10].
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